Unknown

Dataset Information

0

CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function.


ABSTRACT: Increasing knowledge of the function and regulation of tumor-infiltrating lymphocytes has led to new insights in cancer immunotherapy. Regulatory T cells (Treg) accumulate in colon tumors, and we recently showed that CD39+ Treg from cancer patients inhibit transendothelial migration of conventional T cells. CD39 mediates the hydrolysis of ATP to immunosuppressive adenosine and adds to the immunosuppressive effects of Treg. Here, we further investigated the regulatory features of intratumoral CD39+ Treg in colon cancer. Using flow cytometry analyses of cells from 46 colon cancer patients, we confirm the accumulation of CD39+ Treg in the tumor tissue compared to unaffected colon tissue, and also show that tumor-infiltrating Treg express more CD39 and Foxp3 on a per cell basis. Furthermore, CD39+ Treg in tumors express markers indicating increased turnover and suppressive ability. In particular, tumor-infiltrating CD39+ Treg have high expression of surface molecules related to immunosuppression, such as ICOS, PD-L1 and CTLA-4. Functional suppression assays also indicate potent suppressive capacity of CD39+ Treg on proliferation and IFN-? secretion by conventional T cells. In conclusion, our results identify tumor-infiltrating CD39+ Treg as a numerous and potentially important immunosuppressive subset, and suggest that immunotherapy aimed at reducing the activity of CD39+ Treg may be particularly useful in the setting of colon cancer.

SUBMITTER: Ahlmanner F 

PROVIDER: S-EPMC6319332 | biostudies-other | 2018 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

CD39<sup>+</sup> regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function.

Ahlmanner Filip F   Sundström Patrik P   Akeus Paulina P   Eklöf Jenny J   Börjesson Lars L   Gustavsson Bengt B   Lindskog Elinor Bexe EB   Raghavan Sukanya S   Quiding-Järbrink Marianne M  

Oncotarget 20181211 97


Increasing knowledge of the function and regulation of tumor-infiltrating lymphocytes has led to new insights in cancer immunotherapy. Regulatory T cells (Treg) accumulate in colon tumors, and we recently showed that CD39<sup>+</sup> Treg from cancer patients inhibit transendothelial migration of conventional T cells. CD39 mediates the hydrolysis of ATP to immunosuppressive adenosine and adds to the immunosuppressive effects of Treg. Here, we further investigated the regulatory features of intra  ...[more]

Similar Datasets

| S-EPMC5732693 | biostudies-literature
| S-EPMC5006916 | biostudies-literature
| S-EPMC2843758 | biostudies-literature
| S-EPMC5484704 | biostudies-literature
| S-EPMC6882800 | biostudies-literature
| S-EPMC4402269 | biostudies-literature
| S-EPMC5862596 | biostudies-literature
| S-EPMC5900038 | biostudies-literature
| S-EPMC4639983 | biostudies-literature
| S-EPMC7235360 | biostudies-literature